HomeHeadlinesJohnson & Johnson (JNJ) reiterates 2026 is shaping up as a year of accelerated growth and impactAPRIL 14, 2026 AT 12:36 PMJohnson & Johnson (JNJ) reiterates 2026 is shaping up as a year of accelerated growth and impactByNewsquawk StaffImportanceLevel 1#JOHNSON & JOHNSON#JNJ.US#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#JNJ#US EQUITIES
APRIL 14, 2026 AT 12:36 PMJohnson & Johnson (JNJ) reiterates 2026 is shaping up as a year of accelerated growth and impactByNewsquawk StaffImportanceLevel 1#JOHNSON & JOHNSON#JNJ.US#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#JNJ#US EQUITIES
